Latest Advances

  • Condition: Acute Tracheal Necrosis after Intubation with Childhood Onset Systemic Lupus Erythematosus
  • Journal: Chest
  • Treatment Used: High-Dose Steroid Therapy
  • Number of Patients: 1
  • Published —
This case report describes a childhood onset systemic lupus erythematosus patient with acute tracheal necrosis that she developed after intubation.
  • Condition: Systemic Lupus Erythematosus
  • Journal: BioMed research international
  • Treatment Used: Mycophenolate Mofetil
  • Number of Patients: 119
  • Published —
In this study, researchers evaluated the safety and effectiveness of mycophenolate mofetil for the treatment of systemic lupus erythematosus in Japanese patients.
  • Condition: Refractory Noninfectious Uveitis
  • Journal: Yonsei medical journal
  • Treatment Used: Adalimumab
  • Number of Patients: 14
  • Published —
This study tested the safety and efficacy of using adalimumab to treat patients with refractory noninfectious uveitis.
  • Condition: Isolated Libman-Sacks Endocarditis with Primary Antiphospholipid Syndrome
  • Journal: International heart journal
  • Treatment Used: Mitral Valve Repair
  • Number of Patients: 1
  • Published —
This case report describes a patient with isolated Libman-Sacks endocarditis and primary antiphospholipid syndrome.
  • Condition: Patients with Rheumatic Diseases and COVID-19
  • Journal: RMD open
  • Treatment Used: Immunosuppression
  • Number of Patients: 334
  • Published —
This study evaluated risk factors associated with unfavorable outcomes in patients with immune-mediated rheumatic disease (IMRD) and COVID-19.
  • Condition: Ulcerative Colitis
  • Journal: Middle East African journal of ophthalmology
  • Treatment Used: Adalimumab
  • Number of Patients: 1
  • Published —
The study researched the outcomes of Adalimumab in patients with ulcerative colitis.
  • Condition: Severe Interstitial Pneumonia
  • Journal: BMC pulmonary medicine
  • Treatment Used: Aggressive Immunosuppressive Regimen and Extracorporeal Blood Purification with Rapid Reduction of Circulating Autoantibodies
  • Number of Patients: 3
  • Published —
The study researched the outcomes of rapid reduction of circulating autoantibodies for treating severe interstitial pneumonia.
  • Condition: Shrinking Lung Syndrome in Pediatric Systemic Lupus Erythematosus
  • Journal: Pediatric rheumatology online journal
  • Treatment Used: Rituximab
  • Number of Patients: 1
  • Published —
The study researched the outcomes of using rituximab to treat shrinking lung syndrome in pediatric systemic lupus erythematosus.
  • Condition: Lupus Membranous Nephropathy
  • Journal: RMD open
  • Treatment Used: Filgotinib and Lanraplenib
  • Number of Patients: 9
  • Published —
In this study, researchers evaluated the safety and effectiveness of filgotinib and lanraplenib for the treatment of lupus membranous nephropathy.
  • Condition: Systemic Lupus Erythematosus with Chylothorax and/or Chylous Ascites
  • Journal: Medicine
  • Treatment Used: Glucocorticoids, Immunosuppressants, and Surgery
  • Number of Patients: 15
  • Published —
The study researched treatment for systemic lupus erythematosus with chylothorax and/or chylous ascites.
  • Condition: Subacute Progressive Interstitial Lung Disease (ILD) Associated with Systemic Lupus Erythematosus (SLE)
  • Journal: Modern rheumatology case reports
  • Treatment Used: Mycophenolate Mofetil
  • Number of Patients: 1
  • Published —
This case report describes a patient diagnosed with subacute progressive interstitial lung disease (ILD) associated with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
  • Condition: Immune-Mediated Inflammatory Diseases
  • Journal: RMD open
  • Treatment Used: Janus Kinase Inhibitors (JAKi)
  • Number of Patients: 0
  • Published —
This review of the literature examined the safety and effectiveness of Janus kinase (JAK) inhibition in patients with immune-mediated inflammatory diseases (IMIDs).
Showing 1-12 of 166